| Gene symbol | IL3RA | Synonyms | CD123, IL-3R-alpha, IL3R, IL3RAY, IL3RX, IL3RY, hIL-3Ra | Type of gene | protein-coding |
| Chromosome | X|Y | Map location | X;Y | dbXrefs | |
| Description | interleukin 3 receptor subunit alpha | ||||
| Gene symbol | CD33 | Synonyms | CD33rSiglec, SIGLEC-3, SIGLEC3, p67 | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.41 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | CD33 molecule | ||||
| GTO ID | GTC2238 |
| Trial ID | NCT04156256 |
| Disease | Chronic Myeloid Leukemia | Acute Myeloid Leukemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Hematologic Cancer |
| Altered gene | CD123|CD33 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD123/CD33 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Unknown |
| Title | CD123-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies |
| Year | 2018 |
| Country | China |
| Company sponsor | iCell Gene Therapeutics |
| Other ID(s) | ICG136-001 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||
|
|||||||